Jeffrey A. Lieberman, MD
- 24Articles
- 67.6KReads1
- 1998–2016Active
- 66Collaborators
- 123Citations2
About
Jeffrey A. Lieberman, MD, has published extensively on schizophrenia and schizoaffective disorders, focusing on treatment outcomes, antipsychotic drug effectiveness, and neurobiology. His work includes studies on cognitive remediation combined with lurasidone, the impact of second-generation antipsychotics on depressive symptoms, and predictors of medication adherence. Lieberman has also addressed comorbid somatic illnesses in severe mental disorders and explored cost-effectiveness measures in antipsychotic treatment. His research spans from 1998 to 2016 and frequently involves collaboration with Joseph P. McEvoy and Robert A. Rosenheck.
Publications
Cognitive Remediation and Lurasidone in Schizophrenia
June 22, 2016
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
